JULY 24, 2024
Interventions designed to reduce opioid-related overdose deaths were effectively deployed in communities nationwide as part of a National Institutes of Health initiative, but did not result in a statistically significant reduction in overdose death rates during the evaluation period.
Data from the from the NIH HEALing (Helping to End Addiction Long-Term) Communities Study showed that overdose deterring practices—such as increasing naloxone distribution and enhancing access to medication
Interventions designed to reduce opioid-related overdose deaths were effectively deployed in communities nationwide as part of a National Institutes of Health initiative, but did not result in a statistically significant reduction in overdose death rates during the evaluation period.
Data from the from the NIH HEALing (Helping to End Addiction Long-Term) Communities Study showed that overdose deterring practices—such as increasing naloxone distribution and enhancing access to medication for opioid use disorder—were successfully implemented, “demonstrating how leveraging community partnerships and using data to inform public health decisions can effectively support the uptake of evidence-based strategies at the local level,” according to an NIH press release.
The NIH launched the HEALing Communities Study, a four-year, multisite research study to test a set of evidence-based interventions for reducing overdose deaths across healthcare, justice and behavioral health settings.
Researchers identified the COVID-19 pandemic and increased prevalence of fentanyl in the illicit drug market as factors that likely weakened the impact of the intervention on reducing opioid-related overdose deaths.
\The findings were published online in The New England Journal of Medicine (2024 Jun 16).
“This study brought researchers, providers and communities together to break down barriers and promote the use of evidence-based strategies that we know are effective, including medications for opioid use disorder and naloxone,” said National Institute on Drug Abuse Director Nora D. Volkow, MD. “Yet, particularly in the era of fentanyl and its increased mixture with psychostimulant drugs, it’s clear we need to continue developing new tools and approaches for addressing the overdose crisis. Ongoing analyses of the rich data from this study will be critical to guiding our efforts in the future.”
As part of the intervention, researchers collaborated with community coalitions to implement evidence-based practices for reducing opioid overdose deaths from the Opioid-Overdose Reduction Continuum of Care Approach, with a focus on increasing opioid education and naloxone distribution, enhancing access to medication for opioid use disorder, and safer opioid prescribing and dispensing. The intervention also included a series of communication campaigns to help reduce stigma and increase the demand for evidence-based practices.
Communities were randomly assigned to either receive the intervention (between January 2020 and June 2022) or to the control group (between July 2022 and December 2023. To test the effectiveness of the intervention on reducing opioid-related overdose deaths, researchers compared the rate of overdose deaths between the communities that received the intervention immediately with those that did not during the period of July 2021 and June 2022.
Between January 2020 and June 2022, the intervention communities successfully implemented 615 evidence-based practice strategies: 254 related to overdose education and naloxone distribution, 256 related to medications for opioid use disorder, and 105 related to prescription opioid safety.
Despite the success in deploying evidence-based interventions in participating communities, between July 2021 and June 2022, there was no statistically significant difference in the overall rate of opioid-involved overdose deaths between the communities receiving the intervention and those that did not (47.2 opioid-related overdose deaths per 100,000 people in the intervention group vs. 51.7 in the control).
“This study recognizes there is no quick fix to reduce opioid overdose deaths,” said Miriam E. Delphin-Rittmon, PhD, the assistant secretary of Health and Human Services for Mental Health and Substance Use and the leader of the Substance Abuse and Mental Health Services Administration, in a statement. “Saving lives requires ongoing commitment to evidence-based strategies.”
Based on a press release from the NIH.
